Literature DB >> 1805651

Immunoelectron microscopic localization of HLA-DR antigen on mast cells and vessels in normal and tuberculin-reactive skin.

Y Suzumura1, M Ohasi.   

Abstract

We investigated the ultrastructural localization of HLA-DR antigen in normal (NS) and tuberculin-reactive skin (TRS) with the aid of immunoelectron microscopic techniques. Most of the mast cells expressed HLA-DR antigen in TRS, but not in NS. Endothelial cells (ECs) in the microvasculature carried HLA-DR antigen in NS and TRS. The luminal surface of the ECs in NS had a stronger expression of HLA-DR antigen than the abluminal surface. This polar expression of the ECs was maintained in TRS. The percentage of HLA-DR positive junctions on ECs was significantly higher in TRS than in NS. Some of the HLA-DR-positive lymphocytes adhered to the HLA-DR-positive luminal surface of the ECs in NS and TRS. Pericytes and smooth muscle cells of vessels did not carry this antigen in NS or TRS. We discuss the role of mast cells in TRS and the relation between the function and ultrastructural localization of HLA-DR antigen on vessels in NS and TRS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805651     DOI: 10.1097/00000372-199113060-00007

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  3 in total

1.  Cognate interactions between mast cells and helper T lymphocytes.

Authors:  Salvatore Valitutti; Eric Espinosa
Journal:  Self Nonself       Date:  2010-03-17

2.  Role of mast cells as IL10 producing cells in paracoccidioidomycosis skin lesions.

Authors:  Carla Pagliari; Elaine R Fernandes; Fernanda Guedes; Cleiton Alves; Mirian N Sotto
Journal:  Mycopathologia       Date:  2006-11       Impact factor: 2.574

3.  An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing.

Authors:  Kehui Wang; Kevin P Nishimoto; Rita S Mehta; Edward L Nelson
Journal:  J Transl Med       Date:  2006-04-24       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.